Using Thigh Muscle To Fix The Heart
Five million Americans suffer from heart failure, a slow and often fatal weakening of the heart muscle. Various drugs or devices can help ease symptoms and slow the decline somewhat, but the prognosis for advanced cases remains dismal. Now biotech pioneer Genzyme (nasdaq: GENZ - news - people ) and device maker Medtronic (nyse: MDT - news - people ) are teaming up to attack heart failure on a whole new front. They are testing a radical new cell therapy technique that injects new cells into damaged heart muscle in an effort to slow or halt the decline and help restore the heart's functioning.